Abiopharma

EVAXION A/S (EVAX) Files Form 6-K

Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

Academy Sports + Outdoors Announces Preliminary First Quarter Fiscal 2026 Sales Update Ahead of its Analyst Day

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Morningstar DBRS Marks 50 Years of Credit Ratings; Advances Global Methodology Program and Asia-Pacific Growth

NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer

Savara Announces the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) Has Accepted the MOLBREEVI* Marketing Authorisation Application (MAA) for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

📋 Darwish Mohamad (EVP, IHS Nigeria Chief Executive Officer) plans to sell 28K shares of IHS Holding Ltd (at $8.31 each, total $233K) Filed: Apr 07, 2026 | ID: 000140

New Form SCHEDULE 13G/A - abrdn Income Credit Strategies Fund <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001445546-26-002471 <b>Size:</b> 15 KB

Valeo - Déclaration des droits de vote - Mars 2026

Valeo - Voting rights - March 2026

Johnson & Johnson - Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe

Xu Jiayuan 🟡 adjusted position in 214.2K shares (2 derivative) of FinVolution Group (FINV) Transaction Date: Apr 03, 2026 | Filing ID: 015435

Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of interest/ Changes in interest of Directors/ Chief Executive Officer